39 results
Page 2 of 2
8-K
EX-99.1
anph ycr5c2y6i7
8 Nov 22
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm
8-K
EX-99.1
qio1ty3t76kqhediuf2
8 Aug 22
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:03pm
8-K
EX-99.1
7jc078vsd1u mj9t
9 May 22
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm
8-K
EX-99.1
poz19 81fp39kkdej5
28 Feb 22
Results of Operations and Financial Condition
7:46am
8-K
EX-99.1
wlv4pdwlc 3ug
12 Nov 21
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
8:26am
8-K
EX-99.1
poy2afdwz9 ey
12 Aug 21
ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:18pm
8-K
EX-99.1
8qaadc8 7cf2x30aqth
17 May 21
ALX Oncology Reports First Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:10pm
8-K
EX-99.1
yb75qn5hjzzbc2
18 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
ps0rav94 jg8ahe2h
12 Nov 20
ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
4:20pm
8-K
EX-99.1
xhym 7ibtz275sm
27 Aug 20
ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
4:16pm
S-1
EX-10.13
f9e0v
26 Jun 20
IPO registration
4:34pm
DRS/A
EX-10.13
3qoa7xa
12 Jun 20
Draft registration statement (amended)
12:00am
DRS
2zkk 4j2q55jj
5 May 20
Draft registration statement
12:00am